Effect of Antigen Valency on Autoreactive B-Cell Targeting

Area of Science:

• Immunology
• Molecular Biology
• Drug Discovery

Background:

• Autoimmune diseases involve B cells producing self-reactive antibodies.
• Current broad immunosuppressive therapies have adverse effects.
• Targeting autoreactive B cells via their B-cell receptor (BCR) offers a specific approach.

Purpose of the Study:

• To investigate how antigen valency affects B-cell receptor binding, activation, and internalization.
• To identify optimal antigen constructs for selective targeting of autoreactive B cells.
• To lay the groundwork for novel antigen-specific therapies for autoimmune diseases like rheumatoid arthritis.

Main Methods:

• Systematic investigation of mono-, di-, tetra-, and octavalent peptide antigens.
• Utilized a B-cell line engineered to express a BCR specific for citrullinated antigens.
• Assessed BCR binding, activation, and internalization in response to different antigen constructs.

Main Results:

• Dimeric antigen constructs demonstrated superior BCR targeting properties compared to monomeric and multimeric forms.
• Antigen valency significantly influences BCR-mediated cellular responses.
• The dimeric construct showed enhanced binding and internalization characteristics.

Conclusions:

• Dimeric peptide antigens are effective for targeting B cells expressing specific BCRs.
• This study provides a basis for developing antigen-specific therapies for rheumatoid arthritis.
• Optimized antigen constructs can lead to more precise modulation of B-cell activity.